In an ongoing legal dispute between biotech firm Amyris Inc. and cannabinoid producer Lavvan, Amyris has made a recent move to dismiss two claims put forth by Lavvan. The crux of Amyris’ argument lies in the interpretation of the contract term “under.” The company reiterated its position before a Delaware bankruptcy court, stating that the clear definition of the preposition negates the grounds for Lavvan’s claims to progress any further.
According to a report by Law360, the controversy stems from a contract between the two companies. Amyris is contending that the language within the agreement is clear and definitive, particularly focusing on an unambiguous understanding of the preposition ‘under’. By this argument, it holds that Lavvan’s claims should not be permitted to proceed.
For the legal fraternity, this case serves as an important reminder of the crucial role that contract definitions and interpretations play in resolving legal disputes. As the matter unfolds, it will likely be a subject of interest to many legal professionals, not just those working in the biotech and cannabinoid industries, but also in intellectual property law and contractual litigation.
Details about Lavvan’s two claims against Amyris, however, remain unclear due to the paywalled nature of the original article published on Law360. For legal professionals who wish to delve deeper into the reception of Amyris’ argument and its potential implications on contract law and Intellectual Property disputes, Law360 should offer comprehensive coverage on further developments in this case.